Showing results (2821-2830 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 30, 2014
FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangementsDickran Kazandjian, Gideon M Blumenthal, Huan-Yu Chen, et al.
The Oncologist|August 30, 2014
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancerKathryn A Gold, J Jack Lee, Nusrat Harun, et al.
The Oncologist|August 30, 2014
Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial RegistryMarije E Hamaker, Reinhard Stauder, Barbara C van Munster
The Oncologist|July 9, 2014
Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinomaBrigitte Dreno, Nicole Basset-Seguin, Ivor Caro, et al.
The Oncologist|September 11, 2015
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR InhibitorsDavid F Heigener, Christian Schumann, Martin Sebastian, et al.
The Oncologist|February 3, 2016
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant GliomaAmir T Fathi, Brian V Nahed, Seth A Wander, et al.
The Oncologist|January 15, 2016
Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer PatientsOliver Königsbrügge, Florian Posch, Julia Riedl, et al.
The Oncologist|January 16, 2016
Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the LungGlenwood D Goss, Johanna N Spaans
The Oncologist|December 30, 2015
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening TrialPallavi Kumar, Ilana F Gareen, Christopher Lathan, et al.
The Oncologist|May 18, 2016
Referral Criteria for Outpatient Palliative Cancer Care: A Systematic ReviewDavid Hui, Yee-Choon Meng, Sebastian Bruera, et al.
Pageof 571